Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03491683
Title INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Inovio Pharmaceuticals
Indications

glioblastoma

Therapies

Cemiplimab + INO-5401 + INO-9012 + Temozolomide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.